Enzymatic synthesis of dihydrosirohydrochlorin (precorrin-2) and of a novel pyrrocorphin by uroporphyrinogen III methylase  by Warren, Martin J. et al.
Volume 261, number 1, 76-80 FEBS 08106 February 1990 
Enzymatic synthesis of dihydrosirohydrochlorin (precorrin-2) and of a 
novel pyrrocorphin by uroporphyrinogen III methylase 
Martin J. Warren, Neal J. Stolowich, Patricia J. Santander, Charles A. Roessner, Blair A. SowaN and 
A. Ian Scott 
Centre for Biological NMR, Department of Chemistry and #Department of Veterinary Pathology, Texas A & M University, College 
Station, TX 77843, USA 
Received 28 November 1989 
Uroporphyrinogen III methylase was purified from a recombinant hemB- strain of E. coli harbouring a plasmid containing the cysG gene. N-termi- 
nal analysis of this purified protein gave an amino acid sequence corresponding to that predicted from the genetic ode. From the u.v./visible spec- 
trum of the reaction catalysed by this SAM dependent methylase it was possible to observe the sequential appearance of the chromophores of 
a dipyrrocorphin and subsequently of a pyrrocorphin. Confirmation of this transformation was obtained from W-NMR studies when it was dem- 
onstrated, for the first time directly, that uroporphyrinogen is initially converted into dihydrosirohydrochlorin (precorrin-2) and then, by further 
methylation, into a novel trimethylpyrrocorphin. 
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1. INTRODUCTION 
The structure proposed for precorrin-2 (1; R = H), 
an intermediate in vitamin Brz and sirohaem synthesis 
[l-4], is that of a dipyrrocorphin formed by C- 
methylation of uro’gen III at positions 2 and 7 by the 
action of a single SAM-dependent methyl transferase 
[5] as shown in scheme 1. Thus anaerobic isolation of 
the esterified dipyrrocorphin (1; R = Me) and the slight- 
ly enhanced cell free incorporation of the correspond- 
ing octa-acid, compared with that of the oxidised form, 
sirohydrochlorin (= factor II), into cobyrinic acid [3] 
provided strong, but indirect, evidence that (1; R = H) 
is the initial product of the action of uro’gen III 
methylase and that the dipyrrocorphin tautomer is not 
formed by prototropic rearrangement during the pro- 
cess of esterification, isolation and purification. 
The enzyme responsible for the synthesis of 
precorrin-2, SAM-dependent uro’gen methylase, has 
recently been purified from two different sources as a 
direct result of genetic engineering. Blanche et al. [6] 
first described the purification of uro’gen III methylase 
(SUMT) from Pseudomonas denitrificans and, after 
oxidative esterification of the products of the enzymatic 
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reaction, were able to isolate sirohydrochlorin octa- 
methyl ester. However, since no spectral changes were 
observed during the course of the enzymic reaction 
(conducted under anaerobic conditions) is was assumed 
that the initial enzymatic product was the dipyrrocor- 
phin, dihydrosirohydrochlorin (1). 
Recently we reported the purification of uro’gen III 
methylase, the product of the E. coli cysG gene, and 
demonstrated that the enzyme catalysed C-methylation 
of uro’gen III at positions 2 and 7 to form sirohydro- 
chlorin (factor II) after oxidation [7]. In this paper we 
provide direct evidence that the dipyrrocorphin 
tautomer (1) (precorrin-2) is not only synthesised by this 
enzyme but, furthermore, under the appropriate condi- 
tions, acts as a substrate for the enzyme and is trans- 
formed into a trimethylated pyrrocorphin by a further, 
anaerobic SAM-dependent C-methylation step. 
2. MATERIALS AND METHODS 
Specimens of [2,11-“Cz], [3,5-“Cz] and [4,6-“Cz]pbg were syn- 
thesised from the appropriately labelled 5-aminolaevulinic acid as 
previously described [7]. S-Adenosyl [‘3C-methyl]methionine was 
prepared according to the method of Hegazi et al. [8]. Uro’gen III 
methylase was overexpressed and purified as described previously [7] 
from E. coli strain CR256 (RP523/pCAR252). RP523 is a hemB_, 
hemin permeable mutant [9] and, when grown on LB media sup- 
plemented with hemin, is unable to synthesise pbg and hence uro’gen 
III. The enzymes pbg deaminase and uro’gen III synthase (cosyn- 
thase) were also prepared from overproducing recombinant E. coli 
strains as previously described [7]. 
All enzymatic assays were carried out under strictly anaerobic on- 
ditions using buffer that had been degassed by freeze thawing under 
a vacuum of lo-’ Torr. Enzyme mixtures were lyophilised prior to 
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Scheme 1. Pathway to the biosynthesis of modified tetrapyrroles from uro’gen III. Methylation of uro’gen III at positions 2 and 7 by the action 
of uro’gen III methylase commits the pathway towards the biosynthesis of sirohaem and cobalamin via dihydrosirohydrochlorin (precorrin-2) (1; 
R = H). Further methylation of precorrin-2 by uro’gen methylase converts the dipyrrocorphin into a trimethyl pyrrocorphin (2). (The third methyl 
group is shown attached to C-12 but could also be attached to C-18.) 
use. A typical reaction with uro’gen methylase was carried out as 
follows. In 5 ml of 0.1 M potassium phosphate buffer, pH 8.0, were 
dissolved 50 fig of pbg deaminase, 50 fig of uro’gen synthase, up to 
1 mg of uro’gen methylase, 125 ,ug of pbg and 1 mg of SAM. The 
reaction was allowed to proceed at room temperature for l-6 h under 
an atmosphere of argon in a glove box. The reaction was terminated 
by lyophilisation. Termination of larger scale reactions and isolation 
of the reaction products were achieved by the addition of DEAB 
Sephadex which was separated from the reaction mixture by filtration 
through a small sintered column. The column was washed with a large 
excess of buffer and the products were removed from the ion- 
exchange media with a 1 M NaCl solution. Esterification of the prod- 
ucts, when necessary, was carried out as described previously [7]. 
Protein sequencing was carried out using an Applied Biosystems 
470A pulsed liquid protein sequencer. HPLC analysis of the esterified 
reaction products was performed as described previously [7]. Uro’gen 
III concentration was determined after oxidation to uroporphyrin 
with 12 by the HPLC method of Rideout et al. [lo]. “C-NMR spectra 
were obtained at 75.47 MHz on a Bruker WM-300 spectrometer 
equipped with an Aspect 2000 computer. Spectra were recorded at 
ambient temperature (18-20”(Z) in a 10 mm i3C selective probehead 
employing the following acquisition parameters. Repetition delay, 
1.5 s; pulse width, 7.0 fits (60”); acquisiton time, 0.2 s. To avoid ex- 
cessive sample heating, bi-level low power proton decoupling was ac- 
complished using the WALTZ-16 sequence available in the Bruker- 
software. Exponential ine broadening of 5 Hz was applied to the 16K 
data point FID prior to Fourier transformation. 
3. RESULTS AND DISCUSSION 
Uroporphyrinogen III methylase was purified to 
homogeneity from E. coli strain CR256 (RP523/ 
pCAR252) by the same protocol as outlined previously 
[7]. CR256 is a recombinant E. coli hemB_ strain har- 
bouring a plasmid containing the cy.sG gene. The en- 
zyme was purified from this strain because the strain us- 
ed previously, CR252 (TBl/pCAR252), produced a 
large amount of endogenous factor II which was found 
to associate with the protein. By using a hemB- mutant 
strain this problem was overcome as the bacteria could 
no longer make the substrate for the methylating en- 
zyme. 
An N-terminal analysis of the protein gave the amino 
acid sequence shown in table 1. This sequence was 
found to be in complete agreement with that predicted 
by the DNA sequence (Dr Jeff Cole, personal com- 
munication) and has been used to confirm the transla- 
tion start site on the DNA. 
Table 1 
Comparison of the predicted amino acid sequence, derived from the 
CJ& gene, to the amino acid sequence obtained from the N-terminus 
sequencing of uro’gen methylase. The first amino acid predicted from 
the gene sequence (v) is encoded by the triplet GUG which, when it 
acts as the site of translation initiation, encodes for methionine 
Amino acid 







Comparison of the amount of substrate remaining (measured as 
uroporphyrin) to the amount of sirohydrochlorin (Factor II) oc- 
tamethyl ester (obtained by oxidative esterification of the reaction 
products) isolated at the end of a 4 h incubation with differing con- 
centrations of uro’gen methylase 
Reaction no. Methylase con- Amount of Amount of fac- 
centration uro’gen tor II isolated 
(mgjm]) remaining (arbitrary units) 
(nmol/ml) 
1 .OOO 14.0 .OO 
2 .008 12.1 .lO 
3 .020 10.3 .32 
4 .040 6.9 .68 
5 .lOO 2.9 .91 
6 .200 0.0 .lO 
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The effect of different enzyme concentrations on the 
methylation reaction was observed by recording the 
u.v./visible spectrum and by monitoring the disap- 
pearance of uro’gen and the production of sirohydro- 
chlorin by HPLC analysis. As expected the amount of 
uro’gen decreased as the amount of methylase was in- 
creased (table 2). Concurrent with this decrease in sub- 
strate concentration was an increase in the amount of 
sirohydrochlorin isolated from the incubations with 
protein concentrations of up to 0.1 mg/ml (table 2). 
However, at 0.2 mg/ml the amount of sirohydrochlorin 
isolated decreased dramatically (table 2) and a new 
compound, with a longer retention time, was observed 
by HPLC analysis (data not shown). This result sug- 
gested that the enzyme was utilising its intended prod- 
uct as a substrate for further transformation. Addi- 
tional evidence for this transformation was 
demonstrated by the dependence of the u.v./visible 
spectrum with enzyme concentration. As shown in 
fig. 1, when the amount of enzyme was increased up to 
a concentration of 0.1 mg/ml the colour of the incuba- 
tion increased to a dark yellow and a u.v./visible spec- 
trum characteristic of a dipyrrocorphin developed 
[ll, 121. At a protein concentration of 0.2 mg/ml the 
colour of the incubation changed from yellow to red 
and the u.v./visible spectrum changed from that of a di- 
pyrrocorphin to that of a pyrrocorphin [11,12] (fig.1). 
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To confirm that uro’gen III was first being converted 
into a single tautomer of dihydrosirohydrochlorin the 
incubations were repeated on a larger scale using 13C 
enriched substrates, stopped at the ‘dark yellow’ stage, 
and the products analysed by i3C-NMR. Using uro’gen 
III derived from [4,6-13Cz]pbg and [methyl-13C]SAM a
spectrum was obtained which indicated the presence of 
two (singlet) sp’ enriched carbon atoms and two 
(doublet) sp3 enriched centres coupled to SAM derived 
13CH3 at C-2 and C-7 (fig.2a). This spectrum, along 
with the corresponding NMR spectra obtained from in- 
cubations using [2,1 1-13C~] and [3,5-13C2]pbg derived 
substrate, which were all stopped at a similar stage in 
the reaction, provided the necessary proof that 
tautomer (1) was being produced (data not shown) thus 
allowing the unambiguous assignment of the dipyrro- 
corphin form (1) and confirmation that the anaerobic 
esterification sequence [3] had indeed preserved the di- 
pyrrocorphin tautomer intact. 
Fig.1. Ultraviolet/visible spectrum of the reaction catalysed by 
uro’gen methylase after incubation for 4 h. As the methylase concen- 
tration is increased so a spectrum of a dipyrrocorphin develops until, 
at a concentration of 0.2 mg/ml, the spectrum changes to that of a 
pyrrocorphin. 
ed. The three signals in the sp3 region and one in the sp’ 
region are in agreement with a pyrrocorphin structure. 
Incubations with [2,1 1-13Cz] and [3,5-i3Cz]pbg as sub- 
strate were also in accord with structure 2 (or isomers) 
(data not shown). To determine whether all sp3 carbon 
atoms at the termini of the acetic acid side chains had 
undergone methylation, an incubation with [4,6-“Cz]- 
pbg derived uro’gen III was conducted in the presence 
of [methyl-‘3C] enriched SAM. The resultant spectrum 
showed that all three sp3 enriched centres were coupled 
to enriched methyl carbons thus revealing that a third 
methyl group had indeed been attached to the macrocy- 
cle (at C-12 or C-18) (fig.2c). It was also possible, from 
pulse labelling experiments, to determine that these 
methyl groups were added in the sequence C-2>C-7> 
C-12 (or C-18). 
From the u.v./visible spectra presented in fig.1 it There is no known physiological role for the pyrro- 
would appear that uro’gen methylase is also catalysing corphin described in this report, for in E. coli further 
the transformation of the dipyrrocorphin (l), to a methylation of precorrin-2 is not required for sirohaem 
chromophore typical of a pyrrocorphin structure (as 2). synthesis (only oxidation and iron insertion are need- 
This process could occur either by tautomerization or ed), and even in cobyrinic acid synthesis, which has not 
by a further methylation. To differentiate between been demonstrated in E. cofi, such a pyrrocorphin is 
these two possibilities, incubations with the methylase unlikely to be an intermediate [13] since the third and 
were allowed to proceed to the ‘red’ stage using 13C fourth methyl groups are added to C-20 and C-17 
enriched substrates. The products were then again respectively. The synthesis of this pyrrocorphin may 
analysed by NMR. Using uro’gen III derived from therefore be artefactual due to the reaction being car- 
[4,6-13Cz]pbg the spectrum shown in fig.2b was obtain- ried out under non-physiological conditions since, in 
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Fig.2. NMR spectra of the product of the reaction of uro’gen III, derived from [4,6-‘~C~]porphobilinogen, after: (a) incubation with uro’gen 
methylase and S-adeaosyi~methyl-‘3C]methicmine. The reaction was stopped at the ‘dark yellow’ stage. The two signals (doublets) at 48 and 51 ppm 
correspond to the two sp3 enriched carbons at positions 2 and 7 of precorrin-2 (1). The two signals (singlets) at 127 and 129 ppm are due to the 
two sp2 enriched carbons at positions 12 and 17. The signals at about 27 ppm (two singlets) are from the enriched carbons in the propionic acid 
side chain of rings A and B whilst the broad signal at 22 ppm is due to the two enriched carbons in the propionic acid side chain of rings C and 
D (superimposed). The broad signals between 18 and 20 ppm arise from the enriched methyl groups derived from SAM. The other signals (116, 
113 and 21 ppm) are due to unreacted porphobilinogen and uro’gen III. (b) incubation with uroporphyrinogen III methylase and SAM to the final 
‘red’ stage. The three signals between 47 and 52 ppm correspond to the three sp3 centres at positions 2,7 and 12 (or 18) and the signal at 119 ppm 
arises from the sp2 centre at position 18 (or 12) of the pyrrocorphin structure (2). The broad signals (three singlets) at around 27 ppm are due to 
the enriched carbons in the propionic acid side chains of the methylat~ rings A, B and C (or D) whereas the signal at 22 ppm is due to the enriched 
carbon atom of the propionic acid side chain of the remaining unmethylated ring D (or C). (c) as in (b) but using S-adenosyl- 
[methyl-‘3~]methionine. The spectrum corresponds to that observed in (b) except hat the three singlets between 47 and 52 now appear as doublets 
and there is a broad signal between 18 and 20 ppm corresponding to the three SAM derived methyl groups. 
the cell, the ratio of enzyme to substrate would be much 
lower and this in itself would probably prevent the for- 
mation of any pyrrocorphin. However, a uro’gen I 
derived tetramethyiat~d metabolite, factor Sr , contain- 
ing methyl groups at C-2, C-7, C-12 and C-18 has been 
described (141. Perhaps the intrinsic structurai and elec- 
tronic factors reactions in these C-methylations [151 are 
connected with the change from a dipyrrocorphin to a 
pyrrocorphin chromophore with a consequent altera- 
tion in substrate specificity and a different methylase 
may insert the fourth methyl group in factor SI syn- 
thesis. 
These results have revealed for the first time that di- 
pyrrocorphin (1; R = H) is a direct product of uro’gen 
methylase, thereby confirming rigorously the structure 
proposed for precorrin-2. We have also bios~thesised 
the first uroporphyrinogen-derived pyrrocorphin and 
characterised it in its free acid form (2). This is of im- 
portance, since related pyrrocorphins are thought to be 
intermediates in vitamin I312 synthesis [2,4,13]. None of 
these intermediates have, as yet, been isolated, possibly 
due to the severe oxygen sensitivity of these com- 
pounds. We have found that, even after esterification, 
the pyrrocorphin (2) is very unstable when exposed to 
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air and suggest hat the acquisition of the techniques 
necessary for handling this and related pyrrucorph~ns 
will lead to evolution of new strategies for isolation of 
the intermediates of the I312 pathway. 
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